Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017

Array Biopharma (ARRY) Tops Q4 EPS by 4c

August 9, 2017 6:02 AM EDT

Array Biopharma (NASDAQ: ARRY) reported Q4 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $33.8 million versus the consensus estimate of $28.61 million.

Cash, Cash Equivalents and Marketable Securities as of June 30, 2017 were $235.1 million.

For earnings history... More